Label-free electrochemical immunosensor for detection of insulin-like growth factor-1 (IGF-1) using a specific monoclonal receptor on electrospun Zein-based nanofibers/rGO-modified electrode

被引:25
|
作者
Maleki, Fatemeh [1 ]
Rashidi, Mohammad-Reza [2 ]
Razmi, Habib [1 ]
Ghorbani, Marjan [3 ]
机构
[1] Azarbaijan Shahid Madani Univ, Fac Basic Sci, Dept Chem, 53714-161, Tabriz, Iran
[2] Tabriz Univ Med Sci, Pharm Fac, Tabriz, Iran
[3] Tabriz Univ Med Sci, Nutr Res Ctr, Tabriz, Iran
关键词
Insulin-like growth factor 1; Immunosensor; Electrospun nanofibers; Monoclonal antibody; rGO nanoparticle; PAN; Zein-rGO; DRUG-DELIVERY; HORMONE; FIELD;
D O I
10.1016/j.talanta.2023.124844
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A novel electrochemical immunosensor was developed for ultrasensitive determination of the hormone insulin like growth factor 1 (IGF-1) based on immobilization of a specific monoclonal antibody on the electrospun nanofibers of Polyacrylonitrile (PAN)/Zein-reduced graphene oxide (rGO) nanoparticle. The nanofibers deposited on glassy carbon electrode (GCE) showed good electrochemical behaviors with synergistic effects between PAN, Zein, and rGO. PAN/Zein nanofibers were used due to flexibility, high porosity, good mechanical strength, high specific surface area, and flexible structures, while rGO nanoparticles were used to improve the detection sensitivity and anti-IGF-1 immobilizing. Different characterization techniques were applied consisting of FESEM, FT-IR, and EDS for the investigation of morphological features and nanofiber size. The redox reactions of [Fe(CN)6]4-/3-on the modified electrode surface were probed for studying the immobilization and determination processes, using differential pulse voltammetry (DPV) and cyclic voltammetry (CV). Under optimal conditions, LOD (limit of detection) and LOQ (limit of quantification) were obtained as 55.72 fg/mL and 185.73 fg/mL respectively, and sensitivity was acquired 136.29 & mu;A/cm2.dec. Moreover, a wide linear range was obtained ranging from 1 pg/mL to 10 ng/mL for IGF-1. Furthermore, the proposed method was applied for the analysis of IGF-1 in several human plasma samples with acceptable results, and it also exhibited high selectivity, stability, and reproducibility.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] In vitro and in vivo responses to short-term recombinant human insulin-like growth factor-1 (IGF-1) in a severely growth-retarded girl with ring chromosome 15 and deletion of a single allele for the type 1 IGF receptor gene
    de Lacerda, L
    Carvalho, JAR
    Stannard, B
    Werner, H
    Boguszewski, MCS
    Sandrini, R
    Malozowski, SN
    LeRoith, D
    Underwood, LE
    CLINICAL ENDOCRINOLOGY, 1999, 51 (05) : 541 - 550
  • [42] Combined neonatal administration of angiotensin-converting enzyme inhibition (ACE) and insulin-like growth factor-1 (IGF-1) attenuates the renal abnormality induced by a lack of neonatal AT(1) receptor stimulation.
    Friberg, P
    Nitescu, N
    Marcussen, N
    Nilsson, A
    Guron, G
    Adams, MA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A1651 - A1651
  • [43] A sensitive label-free electrochemical immunosensor for detection of cytokeratin 19 fragment antigen 21-1 based on 3D graphene with gold nanopaticle modified electrode
    Zeng, Yan
    Bao, Jing
    Zhao, Yanan
    Huo, Danqun
    Chen, Mei
    Yang, Mei
    Fa, Huanbao
    Hou, Changjun
    TALANTA, 2018, 178 : 122 - 128
  • [44] Insulin-like growth factor-1 (IGF-1) induces WlSP-2/CCN5 via multiple molecular cross-talks and is essential for mitogenic switch by IGF-1 axis in estrogen receptor-positive breast tumor cells
    Dhar, Kakali
    Banerjee, Snigdha
    Dhar, Gopal
    Sengupta, Krishanu
    Banerjee, Sushanta K.
    CANCER RESEARCH, 2007, 67 (04) : 1520 - 1526
  • [45] Expression of insulin-like growth factor-1 receptor (IGF-1R) and p27Kip1 in melanocytic tumors:: A potential regulatory role of IGF-1 pathway in distribution of p27Kip1 between different cyclins
    Kanter-Lewensohn, L
    Dricu, A
    Girnita, L
    Wejde, J
    Larsson, O
    GROWTH FACTORS, 2000, 17 (03) : 193 - 202
  • [46] Sensitivities of erythroid progenitor cells to erythropoietin (EPO) and insulin-like growth factor-1 (IGF-1) in patients with primary familial and congenital polycythemia (PFCP): Studies in strictly serum-free conditions.
    Prchal, JT
    Prchal, JF
    Kralovics, R
    Eskinazi, D
    Axelrad, AA
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 748 - 748
  • [47] A Novel Label-Free Electrochemical Immunosensor for the Detection of Thyroid Transcription Factor 1 Using Ribbon-like Tungsten Disulfide-Reduced Graphene Oxide Nanohybrids and Gold Nanoparticles
    Wang, Wenjing
    Tang, Huabiao
    Zhou, Leiji
    Li, Zhaohui
    MOLECULES, 2024, 29 (02):
  • [48] POTENT CARDIOPROTECTIVE EFFECTS OF LOW DOSE INSULIN-LIKE GROWTH FACTOR-1 (LD-IGF-1) TREATMENT POST MYOCARDIAL INFARCTION ARE MEDIATED THROUGH PHOSPHORYLATION OF THE IGF-1 RECEPTOR, GSK-3BETA INHIBITION AND SURVIVAL KINASE UPREGULATION
    O'Sullivan, John F.
    Leblond, Anne-Laure
    Metharom, Pat
    Kumar, Arun H. S.
    Kelly, Geraldine
    Hristova, Eva
    Hynes, Brian
    O'Connor, Rosemary
    Caplice, Noel M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E2050 - E2050
  • [49] A SARC global collaborative phase II trial of R1507, a recombinant human monoclonal antibody to the insulin-like growth factor-1 receptor (IGF1R) in patients with recurrent or refractory sarcomas
    Patel, S.
    Pappo, A.
    Crowley, J.
    Reinke, D.
    Eid, J.
    Ritland, S.
    Chawla, S.
    Staddon, A.
    Maki, R.
    Vassal, G.
    Helman, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] Insulin-like growth factor-1 receptor (IGF-1R) expression does not predict for resistance to trastuzumab-based treatment in patients with Her-2/neu overexpressing metastatic breast cancer
    Wolfgang J. Köstler
    Gernot Hudelist
    Werner Rabitsch
    Klaus Czerwenka
    Ruth Müller
    Christian F. Singer
    Christoph C. Zielinski
    Journal of Cancer Research and Clinical Oncology, 2006, 132 : 9 - 18